Yu Ge Ran (Yu-Ge Ran)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Drug Administration

Vascular Endothelial Growth Factor

Top Venues

Future oncology (London, England)

Biomarkers in medicine

Expert review of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Yong-Jie Shao, Guo-Dong Yu, Xi Zhang, Yu Ge Ran, Jing-Hua Li
Prognostic value of lymphocyte-C-reactive protein ratio in patients with liver cancer: a meta-analysis. Biomarkers in medicine (2023)
Wen Jie Xie, Shuai Zhang, Lei Su, Yan Hong Li, Xi Zhang, Yu Ge Ran
The efficacy and safety of lenvatinib in the treatment of solid tumors: an up-to-date meta-analysis. Future oncology (London, England) 17 (6) (2021)
Wei Zhang, Li-Jin Feng, Fei Teng, Yan-Hong Li, Xi Zhang, Yu Ge Ran
Incidence and risk of proteinuria associated with newly approved vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: an up-to-date meta-analysis of randomized controlled trials. Expert review of clinical pharmacology 13 (3) (2020)